Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 02 05 2020
accepted: 06 05 2020
pubmed: 22 5 2020
medline: 21 7 2020
entrez: 22 5 2020
Statut: ppublish

Résumé

To investigate olfactory dysfunction (OD) in patients with mild coronavirus disease 2019 (COVID-19) through patient-reported outcome questionnaires and objective psychophysical testing. COVID-19 patients with self-reported sudden-onset OD were recruited. Epidemiological and clinical data were collected. Nasal complaints were evaluated with the sinonasal outcome-22. Subjective olfactory and gustatory status was evaluated with the National Health and Nutrition Examination Survey. Objective OD was evaluated using psychophysical tests. Eighty-six patients completed the study. The most common symptoms were fatigue (72.9%), headache (60.0%), nasal obstruction (58.6%), and postnasal drip (48.6%). Total loss of smell was self-reported by 61.4% of patients. Objective olfactory testings identified 41 anosmic (47.7%), 12 hyposmic (14.0%), and 33 normosmic (38.3%) patients. There was no correlation between the objective test results and subjective reports of nasal obstruction or postnasal drip. A significant proportion of COVID-19 patients reporting OD do not have OD on objective testing.

Identifiants

pubmed: 32437033
doi: 10.1002/hed.26279
pmc: PMC7280665
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1583-1590

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
Clin Otolaryngol. 2015 Feb;40(1):29-35
pubmed: 25269784
Head Neck. 2020 Jun;42(6):1252-1258
pubmed: 32342566
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
Otolaryngol Head Neck Surg. 2002 Jan;126(1):41-7
pubmed: 11821764
Eur J Neurol. 2020 Apr 22;:
pubmed: 32320508
Int Forum Allergy Rhinol. 2019 Oct;9(10):1144-1150
pubmed: 31430061
Laryngoscope. 2007 Feb;117(2):272-7
pubmed: 17277621
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222
Head Neck. 2020 Jul;42(7):1583-1590
pubmed: 32437033
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
Rhinology. 2020 Jun 1;58(3):295-298
pubmed: 32277751
Laryngoscope. 2015 May;125(5):1102-6
pubmed: 25369790
Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134
pubmed: 32340555
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202

Auteurs

Jerome R Lechien (JR)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
Department of Otorhinolaryngology and Head and Neck Surgery, CHU de Bruxelles, CHU Saint-Pierre, School of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

Pierre Cabaraux (P)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Neurology, CHU de Charleroi, Charleroi, Belgium.

Carlos M Chiesa-Estomba (CM)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Universitario Donostia, San Sebastian, Spain.

Mohamad Khalife (M)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Head and Neck Surgery, EpiCURA Hospital, Belgium.

Stéphane Hans (S)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.

Christian Calvo-Henriquez (C)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Otolaryngology-Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.

Delphine Martiny (D)

Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Department of Dean, Faculté de Médecine et Pharmacie, Université de Mons (UMONS), Mons, Belgium.

Fabrice Journe (F)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Leigh Sowerby (L)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France.
Department of Otolaryngology-Head and Neck Surgery, University of Western Ontario, London, Ontario, Canada.

Sven Saussez (S)

Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Department of Otorhinolaryngology and Head and Neck Surgery, CHU de Bruxelles, CHU Saint-Pierre, School of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
Department of Head and Neck Surgery, EpiCURA Hospital, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH